Searched for
MYLAN NV
Cipla rises 2% as drugmaker launches remdesivir generic at Rs 4,000 per vialPharmaceutical major Mylan NV said its generic version of remdesivir will be priced at Rs 4,80009 Jul, 2020, 03.51 PM IST- Mylan gets DCGI nod for remdesivir in India, to launch at Rs 4,800 per vialThe DCGI has approved the company's remdesivir 100 mg per vial for restricted emergency use in India as part of the regulator's accelerated...06 Jul, 2020, 05.31 PM IST
- Dow Jones muted as virus cases rise, jobless claims weighDow Jones Industrial Average was down 2.98 points, or 0.01 per cent, at 26,116.63.18 Jun, 2020, 09.56 PM IST
- Biocon, Mylan launch cancer drug in CanadaFulphila, co-developed by Biocon Biologics and Mylan, was the first biosimilar pegfilgrastim to be approved in the US and was launched in J...28 Apr, 2020, 09.42 PM IST
- Solara Active Pharma to conduct internal probe on Nizatidine API amid Mylan recall"We understand from Mylan NV's press release dated January 8, 2020, that Mylan Pharmaceuticals has initiated a voluntary recall of three lo...09 Jan, 2020, 11.23 AM IST
- Biocon rises 5% after launch of Ogivri in US marketBiotechnology major Biocon and drug firm Mylan NV on Monday announced the launch of biosimilar Ogivri, used for treatment of certain breast...03 Dec, 2019, 03.44 PM IST
- Mylan working with DCGI to launch new TB drug in IndiaMylan will be in a position to launch the product in India soon after receiving approvals from DCGI," Mylans global president and executive...15 Oct, 2019, 04.08 PM IST
- USFDA okays Mylan, Biocon's biosimilar of cancer drug HerceptinOgivri is the first USFDA approved biosimilar to Herceptin and the first biosimilar from Mylan and Biocon's joint portfolio approved in the...02 Dec, 2017, 01.40 PM IST
- “Natco profits to depend on how many rivals get nod for the generic MS drug”“If clarity emerges on the 40-mg version, it will be a very big trigger for Natco”04 Oct, 2017, 09.59 AM IST
- Mylan plans generic EpiPen to quell outcry over $600 costMylan has attracted scrutiny for increasing the treatment’s price 400% in nine years — EpiPen cost $57 for a single pen when the drugmaker ...30 Aug, 2016, 03.37 AM IST
- Mylan launches generic Hepatitis C drug in IndiaDrug firm Mylan NV has launched generic Harvoni tablets, used to treat Hepatitis C, under the brand name 'MyHep LVIR' in India.07 Jan, 2016, 10.13 PM IST
- Mylan fails in $26 bn bid to buy fellow drugmaker PerrigoMylan NV's $26 bn hostile bid for Perrigo collapsed on Friday after the Netherlands-based drugmaker failed to secure at least half of Perri...13 Nov, 2015, 09.50 PM IST
- Mylan launches hepatitis-C Sovaldi tablets in IndiaSovaldi is sold by Mylan's dedicated sales force as part of its Hepato Care segment.04 May, 2015, 02.51 PM IST
- Mylan Pharmaceuticals launches generic hepatitis C drug MyHep in IndiaUS-based company's Indian arm Mylan NV has launched generic Sofosbuvir tablets in strength of 400 mg under the name MyHep in the country, i...24 Apr, 2015, 03.45 PM IST
- Teva bid for Mylan sparks worries of rising generic drug pricesThe increase in generic-drug prices has been a growing concern across the pharmacy industry, affecting mom-and-pop businesses and giant cha...23 Apr, 2015, 02.21 AM IST
- Teva offers to buy Mylan for $40.1 billionTeva, the world’s biggest maker of generic medicines, offered $82 a share in cash and stock for Mylan, according to a statement.22 Apr, 2015, 04.42 AM IST
- US' Mylan eyes MatrixUS-based Mylan Laboratories is believed to be in advanced talks with promoters and private equity funds to buy a majority stake in Matrix L...22 Jun, 2006, 02.02 AM IST
Load More
